Pre-Made Insulin Biosimilar, Recombinant Protein targeting INSR: Recombinant therapeutic protein targeting CD220/HHF5 for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-INN-869

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-INN-869 Category Tag

Product Details

Pre-Made Insulin Biosimilar, Recombinant Protein targeting INSR: Recombinant therapeutic protein targeting CD220/HHF5 is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Insulin is a peptide hormone produced by beta cells of the pancreatic islets; it is considered to be the main anabolic hormone of the body. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of glucose from the blood into liver, fat and skeletal muscle cells. Insulin therapy is often an important part of diabetes treatment.

Products Name (INN Index)

Pre-Made Insulin Biosimilar, Recombinant Protein targeting INSR: Recombinant therapeutic protein targeting CD220/HHF5

INN Name

insulin

Target

INSR

Format

Recombinant Protein

Derivation

Human

Species Reactivity

Human

CH1 Isotype

INS (insulin, IDDM1, IDDM2, "insulin-dependent diabetes mellitus 2") 25-54 (Insulin B chain) 90-110 (Insulin A chain)

VD LC

INS (insulin, IDDM1, IDDM2, "insulin-dependent diabetes mellitus 2") 25-54 (Insulin B chain) 90-110 (Insulin A chain)

Highest_Clin_Trial (Jan '20)

NA

Est. Status

NA

100% SI Structure

NA

99% SI Structure

NA

95-98% SI Structure

NA

Year Proposed

NA

Companies

Eli?Lilly (Indianapolis IN USA)

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

INSR

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide